An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| RCE | RCE Chart Thread | 09/09/25 | 58 | 14K | |||
|
|||||||
| RCE Biotech | RCE Mechanism for action | 09/09/25 | 18 | 4.9K | |||
|
|||||||
| RCE | Ann: Appendix 4G | 29/08/25 | 0 | 195 | |||
|
|||||||
| RCE | Ann: Annual Report to Shareholders | 29/08/25 | 0 | 252 | |||
|
|||||||
| RCE | Ann: Preliminary Final Report | 29/08/25 | 0 | 261 | |||
|
|||||||
| RCE Biotech | RCE in AFR | 28/08/25 | 2 | 486 | |||
|
|||||||
| RCE | Ann: Notification regarding unquoted securities - RCE | 25/08/25 | 0 | 232 | |||
|
|||||||
| RCE | Ann: Quarterly Activities/Appendix 4C Cash Flow Report | 22/08/25 | 62 | 17K | |||
|
|||||||
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.040(8.33%) |
Mkt cap ! $127.2M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 49.0¢ | 44.0¢ | $122.7K | 265.9K |
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8037 | 44.0¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 7247 | 2 |
| Last trade - 16.10pm 10/09/2025 (20 minute delay) ? |
|
|||||
|
Last
44.0¢ |
Change
-0.040 ( 9.13 %) |
||||
| Open | High | Low | Volume | ||
| 49.0¢ | 49.0¢ | 44.0¢ | 82313 | ||
| Last updated 15.14pm 10/09/2025 ? | |||||
| RCE (ASX) Chart |
ASX News
